Exoskeleton Market Segmentation:
Mobility Segment Analysis
In the exoskeleton market, mobile in terms of mobility will lead by capturing the largest revenue share of 65.7% over the forecasted years. The dominance of the segment is attributable to the user-controlled movement, important in rehabilitation clinics and industrial environments. As of the November 2025 article published by ClinicalTrials.gov, the Kessler Foundation has begun conducting a study to evaluate the effectiveness of a wearable robotic exoskeleton (Ekso-GT) in improving mobility, gait, and cognitive function in individuals with multiple sclerosis. Besides, participants are randomly assigned to receive gait rehabilitation using either the robotic exoskeleton or conventional therapy, wherein the outcomes are assessed through the 6-minute walk test, cognitive, and other measures. The study aims to determine if the therapy can enhance walking endurance, cognitive processing, and overall functional mobility over 12 weeks. Hence, the successful demonstration of improved mobility with exoskeletons in MS patients could expand clinical adoption and drive revenue growth in the exoskeleton market.
Extremity Segment Analysis
By the conclusion of 2035, the lower body is anticipated to capture a significant revenue share in the exoskeleton market. The increasing investments, coupled with the rising instances of lower-body disabilities, are the key factors behind this leadership. Simultaneously, the geriatric population and paralyzed patients are also enabling a continued revenue stream in this segment. Moreover, advancements in terms of lightweight materials and improved battery technologies are efficiently enhancing the usability and efficiency of lower-body exoskeletons. Also, the integration of AI and sensor-based systems is readily boosting adoption by offering personalized support and rehabilitation for the afflicted population. Furthermore, government initiatives and healthcare programs that promote mobility aids are expected to drive sustained market growth in the years ahead.
Technology Segment Analysis
In the technology segment powered sub-type is likely to grow at a considerable rate in the exoskeleton market over the discussed timeframe. These powered systems provide active mechanical assistance through actuators and control systems, making them highly essential for clinical rehabilitation and industrial strength support. According to the U.S. FDA in December 2025, a powered exoskeleton is a prescription medical device consisting of external, motorized orthotic components that assist movement of one or multiple lower-extremity joints, such as the hip, knee, or ankle. It is classified as a Class II device under product code PHL; it undergoes 510(k) premarket review by the Office of Neurological and Physical Medicine Devices. Furthermore, the product is designed for medical use; the exoskeleton facilitates rehabilitation and mobility for paralyzed or weakened limbs, relying on controllers and sensors to support safe, controlled movement, hence highlighting their clinical significance and safety requirements for rehabilitation use.
Our in-depth analysis of the exoskeleton market includes the following segments:
|
Segment |
Subsegments |
|
Mobility |
|
|
Extremity |
|
|
Technology |
|
|
End use |
|
|
Form |
|
